Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Imboost
- Development stage
- Unknown
- Lead developer
- SoHo Capital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Imboost is an over-the-counter herbal immune-boosting supplement developed and manufactured by SoHo Global Health. It is formulated to support and strengthen the body's natural immune system, helping to prevent infections and accelerate recovery from illnesses such as the common cold and flu. The core formulation of Imboost contains a synergistic combination of *Echinacea purpurea* extract, which acts as an immunomodulator to regulate immune responses, and zinc picolinate, which provides essential mineral support and antiviral properties. Various line extensions, such as Imboost Force, incorporate additional active ingredients like black elderberry extract for enhanced antioxidant and immune support.
- Brand names
- ImboostImboost BoneImboost ChewyImboost EffervescentImboost ForceImboost Force CoughImboost Force KidsImboost Force UltimateImboost Kids
- Other names
- Echinacea purpurea + zinc picolinateEchinacea purpurea extract + zinc picolinate
02
Targets
TLR4 (Toll-like receptor 4)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CB (Cannabinoid receptors)
Beyond the preview
Go deeper on Imboost.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Imboost.